Condition: Primary Ciliary Dyskinesia · Sponsor: Connecticut Children's Medical Center
This cross-sectional and longitudinal observational study is to gather data on the utility of tests that are used to make a diagnosis of primary ciliary dyskinesia (PCD). There is new testing available, called nasal nitric oxide testing, that non-invasively measures nitric oxide levels in the sinus cavity. Individuals with PCD characteristically have low levels, but this testing does not have extensive data from everyday clinical practice. The objective of this proposal is to improve the diagnostic approach to children and adults with clinical concerns for primary ciliary dyskinesia (PCD).
This description comes directly from the study's public registry record.
Melanie S Collins, MD · 860-545-9440 · mcollin@connecticutchildrens.org
Sigrid M Almeida, BS · 8608375343 · salmeida@connecticutchildrens.org
Always discuss trial participation with your own doctor first.
| Pulmonary Division | Hartford, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05889013